Arteris R&D Spending Growth & History (AIP)
Arteris's r&d spending was $49.9M for fiscal 2025.
View full Arteris company overviewArteris annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $49.9M | $4.9M | +10.89% |
| 2024 | 2024-12-31 | $45.0M | −$121,000 | −0.27% |
| 2023 | 2023-12-31 | $45.1M | $4.0M | +9.62% |
| 2022 | 2022-12-31 | $41.2M | $10.4M | +33.61% |
| 2021 | 2021-12-31 | $30.8M | $13.8M | +81.03% |
| 2020 | 2020-12-31 | $17.0M | — | — |
Arteris quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $16.8M | $4.6M | +37.72% |
| Q1 2026 | 2026-03-31 | $14.5M | $2.6M | +21.88% |
| Q4 2025 | 2025-12-31 | $13.2M | $1.7M | +14.70% |
| Q3 2025 | 2025-09-30 | $12.6M | $725,000 | +6.08% |
| Q2 2025 | 2025-06-30 | $12.2M | $1.5M | +13.57% |
| Q1 2025 | 2025-03-31 | $11.9M | $1.0M | +9.48% |
| Q4 2024 | 2024-12-31 | $11.5M | $869,000 | +8.15% |
| Q3 2024 | 2024-09-30 | $11.9M | $926,000 | +8.42% |
| Q2 2024 | 2024-06-30 | $10.7M | −$1.4M | −11.33% |
| Q1 2024 | 2024-03-31 | $10.8M | −$546,000 | −4.80% |
| Q4 2023 | 2023-12-31 | $10.7M | $345,000 | +3.34% |
| Q3 2023 | 2023-09-30 | $11.0M | −$25,000 | −0.23% |
| Q2 2023 | 2023-06-30 | $12.1M | $1.7M | +16.55% |
| Q1 2023 | 2023-03-31 | $11.4M | $1.9M | +20.36% |
| Q4 2022 | 2022-12-31 | $10.3M | $78,000 | +0.76% |
| Q3 2022 | 2022-09-30 | $11.0M | $3.4M | +44.85% |
| Q2 2022 | 2022-06-30 | $10.4M | $3.9M | +61.42% |
| Q1 2022 | 2022-03-31 | $9.5M | $2.9M | +44.63% |
| Q4 2021 | 2021-12-31 | $10.2M | — | — |
| Q3 2021 | 2021-09-30 | $7.6M | $3.6M | +89.70% |
| Q2 2021 | 2021-06-30 | $6.4M | — | — |
| Q1 2021 | 2021-03-31 | $6.5M | — | — |
| Q3 2020 | 2020-09-30 | $4.0M | — | — |
Arteris r&d spending trends
Over the last five fiscal years, Arteris's r&d spending increased from $17.0M to $49.9M, a change of $32.9M. The latest reported quarter, Q2 2026, shows $16.8M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Arteris source filings ↗